Search

everythinglearnresearchcommunity

for

Search:↓

Baricitinib is effective and safe for severe alopecia areata, working similarly with or without an atopic background.

Modified β-catenin can cause different effects in mouse skin cells, leading to cysts or tumors depending on the cell type.

Deleting TNFα gene reduces skin cancer risk in certain mice.

Researchers created immortal human skin cells with constant testosterone receptor activity to study hair loss and test treatments.

Not having the gene PLAAT3 leads to fat loss, high insulin resistance, and abnormal fat levels in the blood due to a disruption in fat cell development and function.

AD198 is more effective than doxorubicin in stopping certain dog cancer cells.

TGF-β1 increases androgen receptor activity in hair loss, but Hic-5/ARA55 can counter this effect.

Vitamin A treatment reduced abnormal cell growth and improved skin conditions in rats with tumors.

Increasing COX-2 in mouse skin causes bigger sebaceous glands and thinner hair, but stopping COX-2 can reverse hair thinning.

Higher CD8+ T cell levels are linked to Alopecia areata in Iraqi patients.

Upadacitinib helped regrow hair and maintain ulcerative colitis remission.

Increased TEMRA cells can predict treatment outcomes in rapidly progressive alopecia areata.

The enzyme CD73 helps control human hair growth and could be targeted to treat hair growth disorders.

Panitumumab treatment can cause unusual hair growth in some colorectal cancer patients.

Genes linked to fibrosis are more active in people with central centrifugal cicatricial alopecia.

Blocking JAK1 or JAK3 helps reverse hair loss in a mouse model of alopecia areata.

Upadacitinib may help regrow hair in children with alopecia areata and is generally safe.

Topical calcitriol (BPM31543) is safe for preventing hair loss from chemotherapy and shows some effectiveness.

GSH-T levels in hair follicles are similar in smokers and non-smokers and don't increase with certain treatments.

The document doesn't provide a clear conclusion or detailed findings about the impact of certain cells on cancer treatment.

Alpha-difluoromethylornithine prevents cancer in mice but causes hair loss.

AGA patients have fewer hairs and smaller follicles; T:V ratio above 4:1 may indicate AGA.

Overexpressing follistatin in mice delays wound healing and reduces scar size.

Botulinum toxin type A is a safe and effective treatment for male pattern baldness.

Triptolide effectively and safely reduces actinic keratosis lesions in mice.

Centipedegrass extract may promote hair growth by activating certain cell pathways.

The scalp fat tissue of men with hair loss shows changes in gene activity that may contribute to their condition.

A man with Acrodermatitis continua did not get better with etanercept treatment, and his condition worsened, suggesting treatment effectiveness may vary by genetics and race.

CaM7 and CNGC14 interaction controls root hair growth in Arabidopsis.

A form of vitamin E promotes hair growth by activating a specific skin pathway.